Akamai Technologies (NASDAQ:AKAM) signs a $11.6 billion cloud agreement with Anthropic, boosting shares and increasing ...

REGENXBIO reported three-year ALTITUDE trial data for investigational sura-vec in non-proliferative diabetic retinopathy.

Federal Reserve Bank of Cleveland President Beth Hammack says she's concerned that an "inflationary mindset" might set in ...

Addex Therapeutics (NASDAQ:ADXN) regains global rights to GABAB PAM assets from Indivior and evaluates future development ...

Pasqal reported higher quantum services revenue, new quantum system deployments, and expanded cash resources after its ...

Anthropic PBC has signed an $11.6 billion, seven-year contract with Akamai Technologies Inc. for computing power, building on ...

US and Iranian negotiators are exploring a phased deal that would see Tehran reopen the Strait of Hormuz and Washington lift ...

AstraZeneca (NASDAQ:AZN) receives FDA Priority Review for IMFINZI plus enfortumab vedotin in muscle-invasive bladder cancer ...

Torsten Slok, chief economist at Apollo, warns that inflation from rising diesel prices may not be taken into account by the ...

Merck (NYSE:MRK) and Eisai receive FDA approval for WELIREG plus LENVIMA to treat advanced kidney cancer after PD-1/PD-L1 ...

Oil prices fell as markets balanced potential US-Iran diplomatic progress against risks from attacks on Saudi energy ...

XCF Global (NASDAQ:SAFX) reports more than $10 million in August revenue after shipping 1.3 million gallons of renewable ...